EDITORIAL
Accepted on 14 Jan 2025
Editorial: Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions
doi 10.3389/fphar.2025.1546059
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions
Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions
3,134
Total downloads
9,111
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 03 Dec 2024
Combining Acmella oleracea and Boswellia serrata extracts: a novel pharmacological approach in inflammatory vestibulodynia
doi 10.3389/fphar.2024.1508107
- 378 views
ORIGINAL RESEARCH
Published on 03 Dec 2024
Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
doi 10.3389/fphar.2024.1460206
- 322 views
ORIGINAL RESEARCH
Published on 20 Sep 2024
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study
doi 10.3389/fphar.2024.1466824
- 811 views
ORIGINAL RESEARCH
Published on 01 Aug 2024
Evodiamine suppresses endometriosis development induced by early EBV exposure through inhibition of ERβ
doi 10.3389/fphar.2024.1426660
- 958 views
- 1 citation
CLINICAL TRIAL
Published on 22 Mar 2024
A randomized, double-blind, positive-controlled, Phase-II clinical trial to evaluate efficacy and safety of Fuke Qianjin capsule in Pakistani patients with pelvic inflammatory disease
doi 10.3389/fphar.2024.1287321
- 1,218 views
ORIGINAL RESEARCH
Published on 03 Oct 2022
Ningmitai capsules have anti-inflammatory and pain-relieving effects in the chronic prostatitis/chronic pelvic pain syndrome mouse model through systemic immunity
doi 10.3389/fphar.2022.949316
- 2,903 views
- 2 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Impact
- 9,111Topic views
- 5,362Article views
- 3,134Article downloads